Blueprint Medicines Corporation (LON: 0HOJ)
London flag London · Delayed Price · Currency is GBP · Price in USD
113.42
+1.08 (0.96%)
Jan 23, 2025, 5:30 PM BST

Blueprint Medicines Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
5,7294,4022,1754,6544,5782,976
Upgrade
Market Cap Growth
75.11%102.36%-53.26%1.67%53.82%60.09%
Upgrade
Enterprise Value
5,6084,3601,7403,7614,0902,677
Upgrade
Last Close Price
91.2172.0736.7875.0655.6756.63
Upgrade
PE Ratio
----19.91-
Upgrade
PS Ratio
13.4922.4812.8535.007.8759.26
Upgrade
PB Ratio
18.7142.935.096.494.258.49
Upgrade
P/TBV Ratio
18.7142.935.096.494.258.49
Upgrade
P/FCF Ratio
----16.28-
Upgrade
P/OCF Ratio
----16.15-
Upgrade
EV/Sales Ratio
15.9022.2710.2728.287.0453.31
Upgrade
EV/EBITDA Ratio
----17.71-
Upgrade
EV/EBIT Ratio
----18.09-
Upgrade
EV/FCF Ratio
-30.00---14.55-
Upgrade
Debt / Equity Ratio
2.345.931.310.110.060.21
Upgrade
Debt / EBITDA Ratio
----0.27-
Upgrade
Debt / FCF Ratio
----0.23-
Upgrade
Asset Turnover
0.380.210.160.120.650.11
Upgrade
Inventory Turnover
0.890.501.041.69--
Upgrade
Quick Ratio
3.103.515.363.436.864.76
Upgrade
Current Ratio
3.323.765.713.707.094.85
Upgrade
Return on Equity (ROE)
-49.65%-157.13%-75.07%-52.78%32.45%-78.72%
Upgrade
Return on Assets (ROA)
-14.96%-25.34%-25.82%-27.01%15.91%-36.20%
Upgrade
Return on Capital (ROIC)
-17.05%-29.05%-29.60%-30.38%18.20%-46.12%
Upgrade
Earnings Yield
-1.67%-9.04%-21.27%-10.22%5.02%-8.82%
Upgrade
FCF Yield
-3.26%-8.08%-19.50%-4.79%6.14%-7.41%
Upgrade
Buyback Yield / Dilution
-3.11%-1.54%-1.92%-4.18%-17.44%-9.03%
Upgrade
Total Shareholder Return
-3.11%-1.54%-1.92%-4.18%-17.44%-9.03%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.